We investigated the expression and activity of arginine transporters and endothelial nitric oxide synthase (eNOS) in human placental microvascular endothelial cells (HPMEC). Using RT-PCR amplification products for eNOS, CAT1, CAT2A, CAT2B, CAT4, 4F2hc (CD98), rBAT and the light chains y Immunohistochemistry and Western blotting confirmed the presence of 4F2hc and CAT1 protein in HPMEC. 4F2hc-light chain dimers were indicated by a shift in molecular mass detected under nonreducing conditions. L-Arginine transport into HPMEC was independent of Na + or Cl -and was inhibited by the neutral amino acid glutamine, but not by cystine. The K i for glutamine inhibition was greater in the absence of Na + . Kinetic analysis supported a two-transporter model attributed to system y + L and system y + . Expression of eNOS in HPMEC was detectable by immunohistochemistry and ELISA but not by Western blotting. Activity of eNOS in HPMEC, measured over 48 h, either as the basal production of nitric oxide (NO) or as the accumulation of intracellular cGMP was not detectable. We conclude that HPMEC transport cationic amino acids by systems y + and y + L and that basal eNOS expression and activity in these cells is low.
Immunohistochemistry and Western blotting confirmed the presence of 4F2hc and CAT1 protein in HPMEC. 4F2hc-light chain dimers were indicated by a shift in molecular mass detected under nonreducing conditions. L-Arginine transport into HPMEC was independent of Na + or Cl -and was inhibited by the neutral amino acid glutamine, but not by cystine. The K i for glutamine inhibition was greater in the absence of Na + . Kinetic analysis supported a two-transporter model attributed to system y + L and system y + . Expression of eNOS in HPMEC was detectable by immunohistochemistry and ELISA but not by Western blotting. Activity of eNOS in HPMEC, measured over 48 h, either as the basal production of nitric oxide (NO) or as the accumulation of intracellular cGMP was not detectable. We conclude that HPMEC transport cationic amino acids by systems y + and y + L and that basal eNOS expression and activity in these cells is low.
Key words: placenta • arginine • transport • endothelium • eNOS aternofetal exchange in the human placenta occurs across two cellular layers separating maternal and fetal blood, the syncytiotrophoblast and the fetal capillary endothelium. The latter forms an extensive microvascular bed of continuous endothelial cells with intercellular spaces that restrict permeability to large hydrophilic solutes (1) . The phenotype of these endothelial cells is distinguishable from that of larger vessels with respect to specific markers (2) . A recently developed culture model of human placental microvascular endothelial cells (HPMEC) (3) shows phenotypic and barrier properties consistent M with the placental capillary bed. The functional properties of these cells, however, remain largely uncharacterized.
L-Arginine transport by endothelial cells is of particular interest, not only because it is an essential amino acid but also because endothelial cells have the ability to generate nitric oxide (NO) by the action of endothelial nitric oxide synthase (eNOS) using L-arginine as precursor (4) . Furthermore, there are several roles of endothelial-derived NO. NO-induced vasodilation is important in the maintenance of low vascular resistance within the feto-placental circulation (5) , and NO is also known to regulate endothelial permeability, mediate effects of vascular endothelial growth factor (VEGF), and regulate endothelial cell migration and proliferation (6) .
L-Arginine transport into cells can be mediated by several different classes of cationic amino acid transporters. These have been characterized in terms of their ion dependency, substrate specificity, and relative affinity (7) . System y + activity, selective for cationic amino acids only, is encoded for by four genes (CAT1, CAT2, CAT3, and CAT4) representing different isoforms. CAT2 is the only isoform known to have alternatively spliced transcripts (CAT2A and CAT2B). The other three cationic amino acid transporters, systems y + L, b 0+ , and B
0+
, also accept neutral amino acids in a Na + -dependent, Na + -independent, and Na + -and Cl --dependent manner respectively. Systems y + L and b 0+ are heterodimeric amino acid transporters comprised of a heavy chain subunit (4F2hc and rBAT, respectively) with a single membrane-spanning domain, linked via disulfide bonds through an extracellular cysteine to a light chain subunit with 12 putative transmembrane domains (reviewed in refs [8] [9] [10] [11] . Unlike rBAT, which binds one light chain (b 0+ AT1), 4F2hc can complex with different light chain entities, forming heterodimers in which the molecular identity of the light chain confers amino acid transport specificity and transport properties of the heterodimer. For cationic amino acid transport, the light chains y + LAT1 and y + LAT2 are implicated and association of these with 4F2hc confers the ability to transport neutral as well as cationic amino acids.
Here, we characterize the L-arginine (cationic amino acid) transport systems in HPMEC isolated from the fetal capillaries of placentas from normal pregnancies. We have also examined the expression and activity of eNOS in HPMEC.
MATERIALS AND METHODS

Collection of placentas and processing of placental tissue
This study was approved by the Local Research Ethical Committee, and informed consent was obtained. Placentas were collected from St. Mary's Hospital NHS Trust, Paddington, London, or from St. Mary's Hospital, Manchester. Seven placentas were processed within 30 min of delivery following spontaneous labor or elective caesarean section from control pregnancies (35-to 42-wk gestation) with no antenatal complications apart from preterm labor. Ten samples (1-2 cm 3 ) of placental tissue were excized from the basal surface of different cotyledons and thoroughly washed in phosphate-buffered saline (PBS) containing antibiotic (100 µg/ml gentamicin). Six pieces of placental tissue were retained for endothelial cell isolation, and four pieces of tissue were fixed in 4% paraformaldehyde (PFA) in PBS, pH 7.4, for immunohistochemistry.
Occasionally, umbilical cords were also harvested for isolation of human umbilical vein endothelial cells (HUVEC). Placental tissue was stored overnight in a cold storage solution (Viaspan, DuPont Pharmaceuticals Ltd., Letchworth Garden City, UK) before the endothelial cell isolation procedure.
Isolation and culture of HPMEC
HPMEC were cultured from purified capillary fragments as previously described (3), with some modifications. Placental tissue was placed in cold Hanks' balanced salt solution containing 100 µg/ml gentamicin (HBSS/G; Life Technologies, Paisley, UK) and finely dissected to release chorionic villi, which were sieved (50-gauge mesh, Sigma, Poole, UK) to yield intermediate and terminal villous fragments. Following washing twice by centrifugation in HBSS/G (200g for 5 min), villi underwent enzymatic disaggregation with 0.25% trypsin (Sigma) in HBSS/G for 10 min at 37°C, which was terminated by washing twice with HBSS/G plus 1% fetal bovine serum (HBSS/FBS; Harlan Sera Labs, Loughborough, UK). Tissue was further disaggregated with collagenase II (500 U/ml, Sigma, Poole, UK) and dispase (100 U/ml, Sigma) in medium 199 (Life Technologies) with 5% FBS, for up to 2 h at 37°C with gentle agitation. Following two washes in HBSS/G, tissue was treated with trypsin (2.5 mg/ml) and DNase type I (0.1 mg/ml; Sigma) in HBSS/G for 15 min at 37°C. This step was terminated by washing in cold HBSS/FBS, followed by sequential sieving of the tissue fragments through 90, 70, and 40 µm meshes (Biomesh, Merck, Lutterworth, UK) and recovery by centrifugation of the filtrate.
Positive immunoselection of capillary fragments was accomplished as follows: incubation for 30 min at 4°C with anti-thrombomodulin antibody (QB/END40, Serotec, Kiddlington, UK; 10 µg) bound to anti-mouse immunoglobulin-coated P450 Dynabeads (Dynal, Bromborough, UK; 4×10 7 beads) at a ratio of 0.75 bead/cell, and five cycles of magnetic separation and washing in HBSS/FCS. The resulting suspension was concentrated by centrifugation and resuspended in 0.5 ml complete medium (M199 with Earle's salts, bicarbonate, and HEPES supplemented with 20% human AB-positive serum [First Link, Brierley Hill, UK], hypoxanthine/thymidine mixture, 2 mM Glutamax I [Life Technologies], 100 U/ml penicillin, 100 µg/ml streptomycin, 2 µg/ml fungizone, 100 µg/ml endothelial cell growth supplement [ECGS; First Link], and 100 µg/ml heparin [Sigma]). Aliquots (40 µl) of this suspension were added to culture plates precoated with 1% gelatin (Sigma) and pre-equilibrated with 1 ml of complete medium. Cultures were maintained at 37°C in 95% air/5% CO 2 , with replenishment of the medium three times per week. Individual colonies of putative endothelial cells in low-density cultures, as evidenced by cobblestone morphology, were picked and subcultured. The serum concentration in the medium was reduced to 5% when confluence was attained. The phenotype of HPMEC cultures in this study (passage 3-12) was characterized using a panel of markers as described previously (2, 3) . In some instances, two different HPMEC isolates from an individual placenta were selected for further study.
Isolation and culture of HUVEC
HUVEC were isolated according to the method of Jaffe et al. (12) using collagenase/dispase for 10-15 min at 37°C and were cultured in modified complete medium (20% FBS replacing human serum) on 1% gelatin-coated dishes. Primary cultures reached confluence within 3 wk, and experiments were performed on cultures between passage 4-10.
RT-PCR
RT-PCR was used to examine the gene expression of cationic amino acid transporters, associated heavy/light chain regulator proteins, and eNOS by HPMEC. HUVEC were included for comparison, representing a well-characterized large vessel endothelial cell. RNA was extracted from endothelial cell cultures, and integrity was confirmed as described previously (13) . Primers (20-or 23-mers) were designed from GenBank sequences ( Table 1 ). These primers were genespecific, with minimal primer dimer/hairpin formation. PCR was performed over 30-40 cycles at an appropriate annealing temperature, with positive control tissues included. Amplification capacity was confirmed by PCR with β-actin primers (shown in Fig. 1L ). The identity of PCR products was confirmed by restriction enzyme digestion or sequencing.
Western blotting: Preparation of cell lysates
Endothelial cell lysates were prepared from confluent monolayers of HPMEC and HUVEC by scraping cells in chilled PBS containing 0.1 mM aminoethylbenzenesulfonyl fluoride (AEBSF) and either sonication (10 s) or shearing through a 21G needle several times. Protein concentration was determined by the Bradford method using a commercial kit (Bio-Rad Laboratories, Ltd., Hemel Hempstead, UK).
Western blotting for 4F2hc (CD98)
Western blotting of HPMEC protein (30 µg) for 4F2hc was carried out under reducing or nonreducing conditions as described previously (13) . Microvillous plasma membrane (MVM) from human syncytiotrophoblast was included as a positive control (13) .
Western blotting for CAT1
Blots of HPMEC and HUVEC protein (50 µg) were blocked with 3% milk protein/0.05% Tween 
Western blotting for eNOS
HPMEC protein lysates were run in parallel with three positive controls: placental homogenate, HUVEC, and a human aortic endothelial cell lysate supplied with the eNOS antibody (BD Transduction Laboratories, Oxford, UK). Following SDS-PAGE and electoelution, membranes were blocked with 5% milk protein/0.1% Tween for 1 h, followed by incubation with mouse anti-human eNOS monoclonal antibody (1:500) for 1 h in the same buffer. Negative controls were prepared by excluding primary antibody. Immunoreactive species were detected with HRPconjugated sheep anti-mouse antibody (1:1000, Pharmacia Amersham Biotech, Little Chalfont, UK) by ECL. Protein integrity of all samples was confirmed by the detection of a single ~42 kDa band using β-actin antibody (data not shown).
Immunocytochemistry
For immunofluorescent staining of endothelial cells, cultures grown on gelatin-coated glass coverslips were fixed in 4% PFA for 10 min, permeablized with 0.5% Triton-X100 in PBS for 5 min, and then incubated in block buffer (5% BSA in PBS) for 30 min (3). Primary or negative control antibodies (Table 2) , diluted in block buffer, were then applied for 1 h. Bound antibodies were detected with fluorescent secondary antibody conjugates (for polyclonal antibodies) or with biotinylated secondary antibody and streptavidin-Cy3 tertiary reagent (for monoclonal antibodies). In some cases, F-actin was visualized with phalloidin-FITC (100 ng/ml; Sigma). Specimens were viewed with a confocal krypton argon laser scanning fluorescence microscope using TCS-NT software (Leica, UK).
eNOS ELISA
The concentration of eNOS in endothelial cell lysates and placental homogenate (positive control) was measured in triplicate using a Quantikine human eNOS kit according to the manufacturer's instructions (R&D Systems Europe, Ltd., Abingdon, UK). Values were normalized to cell protein content determined by the Bradford method (Bio-Rad).
H arginine transport assay
Confluent monolayers of HPMEC in 35 mm-diameter dishes were washed and pre-equilibrated in control Tyrode's solution (mM: 135 NaCl, 5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 HEPES, 5.6 glucose; pH 7.4) at 37°C for 30-40 min before uptake. All uptake measurements were performed in duplicate. The strategy adopted to distinguish between different cationic amino acid transport systems was similar to that used previously (13) , reliant upon the characteristics of each cationic amino acid transport system as detailed by Devés and Boyd (7) . Essentially, the following properties of arginine uptake were examined: Na + and Cl -dependence (system B 0+ ); Na + independence and lack of inhibition by neutral amino acids (system y + ); Na + independence and inhibition by neutral amino acids, including cystine in the absence of Na + (system b 0+ ); and Na + independence with increased affinity for neutral amino acids in the presence of Na + (system y + L).
Time course and ion dependence of 3 H arginine uptake
The dependence of 3 H arginine uptake by HPMEC on the presence of Na + and Cl -was examined over 10 min. Uptake was initiated by the addition of 1 ml 3 H arginine (1 µCi; 19-26 pmol) in control Tyrode's solution or where Na + (replaced by choline) or Cl -(replaced by gluconate) had been omitted. All uptakes were performed at 37°C and were terminated by the removal of isotope, followed by washing with 25 ml ice-cold Tyrode's buffer and lysis in 1 ml 0.3 M NaOH. An aliquot (0.8 ml) of cell lysate was counted over 5 min in a 2000CA Tricarb Scintillation Counter (Canberra Packard, Ltd., Pangbourne, Berks, UK), and cell lysate protein content was determined by the Bradford method (Bio-Rad).
Kinetic analysis of 3 H arginine uptake
The concentration dependence of 3 H arginine uptake by HPMEC was determined at 10 min by the addition of unlabeled arginine (50 nM to 20 mM) in control Tyrode's solution. Data were analyzed using computer models of the Michaelis-Menten equation with one or two binding components, and the mean sum of the squares of the regression line was compared using the Ftest (SIMFIT; W.G. Bardsley, University of Manchester, UK). A two-transport system model was accepted if the mean sum of squares of the regression line was significantly lower (P<0.05) than that of the one site model; otherwise, the one-transport system model was accepted. Estimates of the Michaelis constant (K m ) and maximal velocity (V max ) were computed by the SIMFIT program.
Effect of amino acids on 3 H arginine uptake
Uptake of 3 H arginine was measured at 10 min in control Tyrode's solution in the presence of either 10 mM leucine, glutamine, lysine, or arginine, or in Na + -free Tyrode's solution in the presence of 0.5 mM cystine. Inhibition by glutamine was further examined in the presence and absence of Na + , over a range of glutamine concentrations (50 nM to 20 mM). Each dataset was fitted by nonlinear regression to a one-transport system model (GraphPad [San Diego, CA] Prism 2.01), and the inhibition constant (K i ) was determined.
Production of NO: Griess reaction
Production of NO by HPMEC was measured as its oxidation products, nitrate and nitrite, using the Griess reaction. Six confluent cultures of HPMEC (in duplicate) were washed twice with PBS and were subsequently maintained in phenol red-free MEM medium (Life Technologies) to reduce assay interference by phenol red, supplemented with 0.5% BSA and insulin/transferrin/selenium supplement (Sigma). After 48 h, conditioned media were collected and centrifuged (at 13,000g for 30 min) through a 10,000 MW cut-off filter (Millipore, Watford, UK), and the filtrate was used to measure nitrate/nitrite concentration by the Griess reaction using two commercial kits (Alexis Corporation (UK), Ltd., Bingham, Nottingham, UK, and R&D Systems Europe, Ltd.). Cell-free culture medium blanks were run concurrently to assess noncellular nitrate/nitrite background.
Production of NO: cGMP ELISA
Intracellular concentration of cGMP was measured by a competition ELISA [detection range, 20-1000 pM; Alexis Corporation (UK), Ltd.] in duplicate. Three confluent cultures of HPMEC were incubated for 24 h in the presence of 100 µM ascorbate and 10 µM sepiapterin. Cultures were washed and incubated in Tyrode's solution with 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM) and superoxide dismutase (SOD, 100 U/ml) with or without L-nitroarginine methyl ester (L-NAME, 1 mM) for 30 min. Arginine (10 mM) was then added to some cultures and incubated for 10 min, followed by either VEGF (100 ng/ml) or A23187 (2 µM). Cultures were incubated for a further 15 min, then lysed in ice-cold ethanol. Samples were acetylated and assayed according to the manufacturer's instructions.
Statistical analysis
All data are given as mean ± SE unless otherwise indicated with n being the number of endothelial cell isolates. Linear regression analysis and statistical comparisons were performed using GraphPad Prism version 2.1.
RESULTS
Characterization of HPMEC cultures
The primary characteristic used to identify HPMEC cultures in this study was the adoption of cobblestone morphology, which is associated with the expression of tight junction and adherens junction proteins (VE-cadherin, occludin, claudin-1, ZO-1) (3). The phenotype of the cultures used in this study conformed to that reported previously with respect to the expression of proteins such as ACE, endoglin, CD54, and caveolin-1 (data not shown), which are features of the placental villous endothelium (2) . In addition, purity of these cultures was confirmed by an absence of immunoreactivity for α-smooth muscle actin and the fibroblast marker AS02, which identify pericytes (2).
Expression of cationic amino acid transporters in HPMEC
RT-PCR
Expression of mRNA in HPMEC for various cationic amino acid transporters, heavy and light chain components, and eNOS is shown in Figure 1 . Positive identification of gene expression was inferred when a PCR product of the predicted size comigrated with that in the positive control lane(s). Additional PCR controls using reverse transcriptase-untreated RNA in parallel with cDNA confirmed the absence of genomic DNA in samples (data not shown). Amplification products for CAT1 (Fig. 1A), CAT2A (Fig. 1B), CAT2B (Fig. 1C), CAT4 (Fig. 1D), 4F2hc (Fig.  1E) , y + LAT1 (Fig. 1F ), y + LAT2 (Fig. 1G) , and eNOS (Fig. 1K) were detected in both HPMEC and HUVEC, with a tendency to a more uniform signal intensity in the latter. A lack of signal for B 0+ was common to both cell types (Fig. 1H) . A notable difference between the two types of endothelial cells was the lack of rBAT and almost undetectable b 0+ AT1 light chain signal in HUVEC (Fig. 1I, 1J ).
Western blotting for 4F2hc (CD98)
Signal was observed in all five HPMEC isolates using an anti-4F2hc (CD98) antibody under reducing conditions. The predominant band of 85 kDa and the higher molecular weight moieties at ~135 kDa were also evident in the MVM positive control (Fig. 2A) . Under nonreducing conditions, a major protein band of 135 kDa was apparent in four of the five HPMEC isolates, which comigrated with that in MVM (Fig. 2B) . The higher molecular weight doublet, which was visible in MVM, but not HPMEC, under nonreducing conditions (Fig. 2B) , persisted after preincubation with antigenic peptide (data not shown). All other signals were abolished by preincubation with antigen under both conditions (data not shown). Figure 3 shows cytochemical staining of HPMEC and HUVEC for 4F2hc. Staining appeared granular and uniformly spread over the cell surface (Fig. 3A, 3C ) and was not polarized, appearing throughout the cytoplasm (Fig. 3B and 3D ). Nonreactive antibody gave no signal using identical microscope settings (not shown).
Immunocytochemistry for 4F2hc (CD98)
Western blotting for CAT1
In contrast to the single band of 67 kDa detected in HUVEC (Fig. 4A) , a doublet was apparent in all three HPMEC isolates under reducing conditions (Fig. 4B) . For each isolate, the lower band (79 kDa) was more intense than the upper band (90 kDa). Signal was abolished in the absence of primary antibody (data not shown).
Immunocytochemistry for CAT1
CAT1 immunoreactivity in HPMEC was characterized as fine membrane-associated punctate staining, with intense cytoplasmic staining also clearly visible, which demonstrated partial polarization to the apical side (Fig. 5 ). Nonreactive antibody gave no signal using identical microscope settings (not shown).
Functional characterization of cationic amino acid transporters in HPMEC
Time course of 3 H arginine uptake
Uptake of 3 H arginine was linear over 10 min under all conditions examined (shown only for control conditions, Fig. 6 ). Thereafter, uptake of 3 H arginine was measured at 10 min.
Kinetics of 3
H arginine uptake Figure 7 shows 3 H arginine (19-26 nM) uptake by HPMEC at 10 min in the presence of unlabeled L-arginine over the range 50 nM to 20 mM. Comparison of individual HPMEC datasets to one-or two-site transport component models revealed seven out of the nine isolates supported a two-site model as the better fit. In the two isolates in which the one-site binding fit was preferred, the affinity constant (K m ) fell within the range of K m values derived for the higher affinity site of the other isolates and was taken to represent this component. The kinetic parameters of the higher affinity and lower affinity transport systems were K m 1.8 ± 0.6 and 86.5 ± 23.1 µM and V max 19.3 ± 7.4 and 198.5 ± 37.8 pmol/mg protein/10 min, respectively.
Effect of amino acids and ion substitution on 3 H arginine uptake
The effect of neutral and cationic amino acids, and of Na + and Cl -depletion, on 3 H arginine uptake by HPMEC is shown in Figure 8 . Addition of 10 mM glutamine caused a marked reduction in uptake. This glutamine-sensitive component accounted for ~66% control uptake. Likewise, a leucine-sensitive component (~51-59% control uptake) was apparent in each HPMEC isolate studied. Lysine and arginine were both effective in abolishing 99% uptake, demonstrating that both the glutamine-sensitive and -insensitive components were inhibitable by these cationic amino acids. 3 H arginine uptake was unaltered by the removal of extracellular Na + or Cl -, or by the addition of 0.5 mM cystine under Na + -free conditions.
The Na + -dependency of glutamine inhibition of arginine uptake was examined further. All three isolates studied exhibited a shift in the concentration dependence of glutamine inhibition in the absence of Na + , demonstrating that the affinity for glutamine had been reduced under this condition (Fig. 9) . The maximal inhibition achieved by glutamine in the presence or absence of Na + was similar, a residual glutamine-insensitive component remaining under both conditions. Using the K m for the high-affinity system to calculate K i , we observed an increase in K i for Lglutamine from 120 ± 38 to 927 ± 251 µM (mean ± SE, n=3) in control and Na + -free Tyrode's solution, respectively.
Expression of eNOS and production of NO by HPMEC
Western blotting for eNOS
Signal for eNOS, visualized as a single band of 140 kDa, was clearly detectable in large vessel endothelial cells (HUVEC and human aortic endothelial cells) and human placental homogenate at relatively short exposure times (Fig. 10 ) and was abolished in the absence of primary antibody (data not shown). However, we were unable to detect eNOS in any of the five HPMEC isolates despite the higher protein loadings, even with prolonged exposures. Note that these were the same HPMEC lysates that demonstrated CD98 immunoreactivity in Fig. 2 .
Immunocytochemistry for eNOS
Immunoreactivity for eNOS was observed in HPMEC and HUVEC using a polyclonal antibody, with stronger signal intensity in HUVEC (Fig. 11) . Reactivity showed a punctate distribution in both cell types, apparent at the cell surface and also within the cytoplasm, which in the case of HPMEC, by reference to the F-actin cytoskeleton, showed partial polarization toward the apical surface (Fig. 11B) . Signal for eNOS was also detected in HPMEC with the same monoclonal antibody that was used in Western blotting, although a secondary/tertiary amplification step was required for detection (data not shown).
Determination of eNOS concentration by ELISA
The cellular concentration of eNOS (pg/mg protein) in HPMEC (48 ± 13, n=11) was significantly lower (by two orders of magnitude) than that found in HUVEC (3561 ± 987, n=5; P<0.01) and placental homogenate (1123 ± 252, n=3; P<0.05, ANOVA with Bonferroni's multiple comparison test).
Production of NO
Basal production of NO by HPMEC over 48 h was undetectable using nitrate reductase and subsequent detection of nitrite by the Griess reaction. This result was confirmed independently using two commercial kits with detection ranges of 5-35 µM (Alexis Corporation) and 0.0624-20 µM (R&D Systems). Furthermore, we were unable to detect any intracellular accumulation of cGMP following stimulation with extracellular arginine, VEGF, or A23187.
DISCUSSION
Expression and characterization of arginine transporters in HPMEC
In this study, we have characterized the transporters involved in arginine uptake by HPMEC using molecular, immunochemical, and functional approaches. This multifaceted strategy allowed us to discriminate clearly which cationic amino acid transporters are functionally active in HPMEC.
Moieties belonging to different classes of cationic amino acid transporters were detectable at the mRNA level in HPMEC. The detection of CAT1 mRNA and protein in HPMEC accords with its ubiquitous expression in different cell types other than the liver (7) . Note that the molecular mass of CAT1 differed between HUVEC and HPMEC. The single protein species of 67 kDa detected in HUVEC agrees well with that reported by others in pulmonary artery endothelial cells using the same antibody (14) and is consistent with predicted molecular mass of deglycosylated human CAT1 (15) . In contrast, the CAT1 protein doublet observed in HPMEC leads to the speculation that CAT1 is glycosylated to varying degrees in this cell type, the molecular masses detected falling within the range for glycosylated CAT1 in other endothelial cells (80-100 kDa) (15) .
The cell surface distribution of CAT1 in HPMEC was punctate, as has been observed for other endothelial cells, although it remains to be determined whether this reflects microdomain associations with cytoskeletal proteins or other membrane proteins such as caveolin (16, 17). Our evidence of CAT1 cytoplasmic staining could indicate trafficking from Golgi to the plasma membrane or targeting to mitochondria (18). Localization of CAT1 to the Golgi would be consistent with our speculation that this protein undergoes glycosylation. Furthermore, our demonstration of system y + activity in HPMEC indicates that functional CAT1 protein has been inserted in the apical plasma membrane, also implicated in HUVEC (19-21). Whether such plasma membrane insertion of CAT1 in HPMEC relies on amino acid targeting motifs or the relative distribution of CAT1-associated membrane proteins (17) remains to be determined.
The intense PCR product for 4F2hc (CD98) in HUVEC and HPMEC provides evidence that this gene is expressed in different endothelial cell types. 4F2hc has a widespread cell and tissue distribution, which may be accounted for by its multiple functions and involvement in various, often disparate, cellular processes (9). Our observation of mRNA for 4F2hc and both y + LAT1 and y + LAT2 light chains in HPMEC has been reported previously in HUVEC (21). This coexpression of y + LAT1 and y + LAT2 light chains in the same cell type allows for the possibility that either of these may form heterodimeric complexes with 4F2hc. Indeed, support for the formation of 4F2hc-light chain dimers via a disulfide bond in HPMEC comes from the observation that there is a shift in 4F2hc immunoreactive protein from 135 kDa to a predominant 85 kDa moiety following reduction, consistent with previous observations (13, 22) . This difference in molecular mass agrees well with the predicted size of 56 kDa for both y + LAT1 and y + LAT2 (10) and therefore does not allow us to distinguish which light chain ligand is associated with 4F2hc. Light chain y + LAT1 is perhaps favored by its broad tissue distribution over y + LAT2, which has limited expression in transporting epithelia and endothelial cells (8, 10) , although our PCR data shows more uniform gene expression for the latter.
Collectively, the RT-PCR, Western blot, and immunocytochemical data indicate the coexistence of CAT1 and 4F2hc proteins in HPMEC. We therefore hypothesized that arginine uptake by HPMEC would be mainly by systems y + and y + L, respectively. The functional characterization strategy we adopted not only allowed the individual contributions of these systems to be measured but also allowed any contribution from other potential cationic amino acid transporters to be eliminated. As systems y + L and y + interact with neutral amino acids with markedly different affinities (23), the rate of arginine influx through these systems can be determined in the presence of a neutral amino acid such as glutamine, the inhibitable fraction representing system y + L activity and the residual fraction representing system y + activity (13).
Our demonstration that 3 H arginine uptake by HPMEC is Na + -independent, sensitive to both glutamine and leucine but not fully inhibitable by these amino acids, and is abolished by excess unlabeled arginine, fully supports our contention that systems y + L and y + mediate cationic amino acid transport in this cell type. Furthermore, the increase in the K i of glutamine when Na + was replaced by choline confirms the positive identification of system y + L activity (24). Our observation that the Na + dependence of inhibition was lost at high substrate concentration is also a feature of system y + L activity (7).
The lack of Na + -or Cl --dependent arginine uptake by HPMEC indicates a lack of involvement by system B o+ (25), corroborated by our failure to detect mRNA for this transporter. Despite the detection of mRNA for rBAT and light chain b 0+ AT1 in HPMEC, our failure to find any evidence of system b 0+ activity in HPMEC, as manifested by the inability of cystine to inhibit arginine uptake (26) , makes it improbable that rBAT interacts with b 0+ AT1 to form a heteromeric, functional transport complex (10) in this cell type.
Our assertion that only the two transport systems, y + and y + L, mediate arginine uptake in HPMEC is supported further by the derivation of kinetic parameters favoring a two-transport system model for arginine uptake. We attribute the higher affinity system (K m ~2 µM) to system y + L, based on the affinity constant being of the same order of magnitude as that previously reported for system y + L (5-10 µM) (10) . Likewise, the K m of the lower affinity system (Km ~87 µM) accords well with values previously reported for CAT1-mediated system y + activity (110-160 µM) (27) . Mediation by isoforms other than CAT1 is unlikely based on the identification of only one low-affinity transport system kinetically, and the higher K m values for the other CAT isoforms (3.36-3.9 and 0.32-0.73 mM for CAT 2A and CAT 2B, respectively; K m for CAT 4 remains undetermined, and it may not be functional alone [27, 28] ).
Note that HUVEC and HPMEC, as examples of macro-and microvascular endothelial cells from the same tissue, both mediate arginine transport by systems y + and system y + L (21), yet they exhibit marked differences in the relative expression of eNOS. This leads to the speculation that systems y + and y + L might subserve different functions in these cell types, supplying arginine to distinct intracellular compartments. System y + L, being the lower capacity system, will be saturated at arginine concentrations found within the fetal plasma (72 µM) (29) . However, as this system is a neutral amino acid exchanger, it could generate high intracellular concentrations of neutral amino acids. This notion is consistent with the observation that glutamine is the most prevalent intracellular amino acid in some endothelial cells (30) . System y + , on the other hand, being a higher capacity system is unlikely to be saturated with respect to arginine at physiological levels but is potentially able to respond to perturbations in local concentrations. Certainly, the subcellular localization of these transporters in HPMEC merits further study.
Expression of eNOS and lack of NO production by HPMEC
Our data suggest that HPMEC represents an unusual endothelial phenotype in that eNOS expression is remarkably low, below the threshold of detection by Western blotting. This, however, accords with the undetectable/low eNOS abundance reported within the fetal capillary endothelium in situ (31) (32) (33) . Furthermore, it demonstrates that this eNOS phenotype is retained by HPMEC after isolation and culture. In contrast, the high abundance of eNOS within the syncytiotrophoblast and vascular endothelium of larger fetal vessels (31-33) allowed eNOS to be readily detected in HUVEC and placental lysates by both Western blotting and ELISA.
The partial polarization of eNOS to the apical surface in HPMEC would be consistent with it being targeted to plasmalemmal caveolae. However, we do not observe any eNOS/caveolin-1 colocalization in HPMEC (data not shown). This lack of colocalization of eNOS with caveolin-1 in HPMEC is unusual and does not conform to the paradigm that these two proteins are complexed within caveolae of endothelial cells (16, 34, 35) .
The low expression of eNOS in HPMEC is consistent with our failure to detect NO synthesis by these cells. Attempts to measure NO production by the Griess reaction following stimulation with extracellular arginine or agonists (A23187 or VEGF) were also unsuccessful, as were strenuous attempts to detect NO production using NO-sensing electrodes (World Precision Instruments; data not shown). These negative findings undoubtedly relate to the low level of cellular expression of eNOS in HPMEC, as in HUVEC, in which eNOS concentration is 74-fold greater (as determined by ELISA), both basal and agonist-stimulated NO synthesis is detectable by the Griess reaction (36, 37) and using a NO-selective electrode (38) . The absence of any increase in cGMP with the above stimuli implies that NO synthesis in HPMEC is below the threshold for activation of guanylate cyclase.
If these data reflect the situation in vivo, then NO production by the fetal microvasculature makes only a minor contribution to the maintenance of low vascular tone in the feto-placental circulation. The ability of HPMEC to transport cationic amino acids, despite the absence of eNOS activity, indicates these transporters are important for other metabolic requirements of these cells. However, it is also possible that this may contribute to the overall maternofetal transport of cationic amino acids such as lysine and arginine by affecting the concentration of amino acids in the interstitial space, influencing the transplacental concentration gradient. Such a role of the endothelium, in addition to that of the syncytiotrophoblast, has not been considered previously and would be dependent on a polarized distribution of transporters. 3 H arginine uptake was measured at 10 min in control (C), Na + -free (-Na), or Cl --free (-Cl) Tyrode's solution either alone or in the presence of 10 mM leucine (Leu), glutamine (Gln), lysine (Lys), arginine (Arg) or 0.5 mM cystine (Cyst). Data are mean ± SE, with the number of HPMEC isolates given in parentheses. 3 H arginine uptake was Na + -and Cl --independent and inhibited by glutamine, lysine, and arginine. *P<0.05, **P<0.001 vs. C (ANOVA with Bonferroni's multiple comparison test). 3 H arginine uptake was measured at 10 min in control (■) or Na + -free (▼) Tyrode's solution in the presence of varying concentrations of L-glutamine (50 nM to 20 mM). K i was calculated using the K m for the high-affinity system. Data are mean ± SE, n = 3 HPMEC isolates. 
